Literature DB >> 29376606

[The role of the uretral catheter in the development of catheter- related urinary tract infection].

A O Vasilyev1,2, A V Govorov1,2, A A Shiryaev1,2, D Yu Pushkar1,2.   

Abstract

The most common source of nosocomial infection is the urinary tract, especially if they it is drained with a urethral catheter. Catheter-associated urinary tract infections account for at least 80% of all complicated urinary tract infections and are the most common type of hospital-acquired infection. Intestinal microflora plays the leading role in the pathogenesis of catheter-associated urinary tract infections, whereas the most important risk factor for their development is the long duration of urinary catheter drainage. In the case of short-term and intermittent catheterization, routine antibiotic prophylaxis is not required, but if a patient develops clinically significant infection, antibiotic therapy is required followed by definitive therapy based on culture. Urethral catheters coated with antimicrobial substances and anti-inflammatory agents can significantly reduce the adhesion and migration of bacteria, thereby reducing the incidence of urinary tract infections. Despite this, the incidence of catheter-associated infection remains high. We have reviewed recent literature related to catheter-associated urinary tract infections and the best means of preventing this condition.

Entities:  

Keywords:  catheter-associated urinary tract infections; infectious complications of the urinary tract; urethral catheter

Mesh:

Year:  2017        PMID: 29376606

Source DB:  PubMed          Journal:  Urologiia        ISSN: 1728-2985


  2 in total

1.  Urinary tract infection control in intensive care patients.

Authors:  Yan Liu; Dong Xiao; Xiao-Hui Shi
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 2.  Polymer Conjugates of Antimicrobial Peptides (AMPs) with d-Amino Acids (d-aa): State of the Art and Future Opportunities.

Authors:  Ottavia Bellotto; Sabrina Semeraro; Antonella Bandiera; Federica Tramer; Nicola Pavan; Silvia Marchesan
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.